Vázquez VMEF

Idioma: Español
Referencias bibliográficas: 27
Paginas: 50-54
Archivo PDF: 66.05 Kb.

RESUMEN

La obesidad es una enfermedad que forma parte del síndrome metabólico y la cual se ha descrito como un problema de salud pública en nuestro país y zonas industrializadas a nivel mundial. El entendimiento de los factores que conllevan al desarrollo de dicha enfermedad es esencial para su tratamiento. El producto del gen de la obesidad, la leptina, es el responsable de mantener el equilibrio energético en los animales. Esta revisión tiene como objeto describir la vía de señalización de la leptina y las moléculas involucradas en ella, así como determinar las perspectivas farmacológicas y nutricias para el tratamiento de la resistencia a la leptina que acompaña a la obesidad.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Coleman DL (1973) Effects of parabiosis of obese with diabetes and normal mice. Diabetologia 9: 294-298

2. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372: 425-432.

3. Green ED, Maffei M, Braden VV, Proenca R, DeSilva U, Zhang Y, Chua SC Jr, Leibel RL, Weissenbach J, Friedman JM (1995) The human obese (OB) gene: RNA expression pattern and mapping on the physical, cytogenetic, and genetic maps of chromosome 7. Genome Res 5: 5-12.

4. Bjorbaek C, Uotani S, da Silva B, Flier JS (1997) Divergent signaling capacities of the long and short isoforms of the leptin receptor. J Biol Chem 272: 32686-32695.

5. Tartaglia L A, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J, Muir C, Sanker S, Moriarty A, Moore KJ, Smutko JS, Mays GG, Wool EA, Monroe CA, Tepper RI (1995) Identification and expression cloning of a leptin receptor, ObR. Cell 83: 1263-1271.

6. Bazan JF (1990) Structural design and molecular evolution of a cytokine receptor superfamily. Proc Natl Acad Sci USA 87: 6934-6938.

7. Heim MH (1996) The Jak-STAT pathway: specific signal transduction from the cell membrane to the nucleus. Eur J Clin Invest 26: 1-12.

8. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, Friedman JM (1996) Abnormal splicing of the leptin receptor in diabetic mice. Nature 379: 632-635.

9. Ghilardi N, Ziegler S, Wiestner A, Stoffel R, Heim MH, Skoda RC (1996) Defective STAT signaling by the leptin receptor in diabetic mice. Proc Natl Acad Sci USA 93: 6231-6235.

10. Uotani S, Bjorbaek C, Tornoe J, Flier JS (1999) Functional properties of leptin receptor isoforms. Diabetes 48: 279- 286.

11. Chan JL, Bluher S, Yiannakouris N, Suchard MA, Kratzsch J, Mantzoros CS (2002) Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans. Diabetes 51: 2105-2112.

12. Wauters M, Considine R, Van Gaal LF (2000) Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 143: 293-311.

13. Devos R, Guisez Y, Van der Heyden J, White DW, Kalai M, Fountoulakis M, Plaetinck G (1997) Ligand-independent dimerization of the extracellular domain of the leptin receptor and determination of the stoichiometry of leptin binding. J Biol Chem 272: 18304-18310.

14. Ihle JN (1995) Cytokine receptor signaling. Nature 377: 591-594.

15. Bahrenberg G, Behrmann I, Barthel A, Hekerman P, Heinrich PC, Joost HG, Becker W (2002) Identification of the critical sequence elements in the cytoplasmatic domain of leptin receptor isoforms required for Janus kinase/ signal transducer and activator of transcription activation by receptor heterodimers. Mol Endocrinol 16: 859-872.

16. Bates S, Myers M (2004) The role of leptin-STAT 3 signaling in neuroendocrine function: an integrative perspective. J Mol Med 82: 12-20.

17. Bendinelli P, Maroni P, Pecori Giraldi F, Piccoletti R (2000) Leptin activates Stat3, Stat1, and AP-1 in mouse adipose tissue. Mol Cell Endocrinol 168: 11-20.

18. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K (1997) A new protein containing and SH2 domain that inhibits JAK kinases. Nature 387: 921-924.

19. Nicholson SE, Wilson TA, Farley A, Starr R, Zhang JG (1999) Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J 18: 375-385.

20. Bjorbaek C, El-Haschimi K, Frantz JD, Flier JS (1999) The role of SOCS-3 in leptin signaling and leptin resistance. J Biol Chem 274: 30059-30065.

21. Espanel X, Walchli S, Gobert RP, El Alama M, Curchod ML, Gullu-Isler N, van Huijsduijnen RH (2001) Pulling strings below the surface. Endocrine 15: 19-28.

22. Barr VA, Malide D, Zarnowski MJ, Taylor SI, Cushman SW (1997) Insulin stimulates both leptin secretion and production by rat white adipose tissue. Endocrinology 138:4463-4472.

23. Niswender KD y Schwartz M (2003) Insulin and leptin revisted: adiposity signals with overlapping physiological and intracellular signaling capabilities. Front neuroendocrinol 24:1-10.

24. Kim JB, Uotani S, Pierroz D, Flier J, Kahn B (2000) In vivo administration of leptin activates signal transduction directly in insulin-sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 141:2328-2339.

25. Plum L, Schubert M, Brüning J (2005) The role of insulin receptor signaling in the brain. Trends Endocrinol Metab 16: 59-65.

26. Tappia PS, Ladha S, Clark DC, Grimble RF (1997) The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cytokine production in rats fed a variety of fat diets. Mol Cell Biochem 166:135-143.

27. Sengupta TK, Schmitt EM, Ivashkiv LB (1996) Inhibition of cytokines and JAK-STAT activation by distinct signaling pathways. Proc Natl Acad Sci USA 93:9499-9504.